Multifunctional Regulatory Protein Connective Tissue Growth Factor (CTGF): A Potential Therapeutic Target for Diverse Diseases

Overview

Journal Acta Pharm Sin B

Publisher Elsevier

Specialty Pharmacology

Date 2022 Jul 18

PMID 35847511

Authors

Minyang Fu

Dandan Peng

Tianxia Lan

Yuquan Wei

Xiawei Wei

Affiliations

Soon will be listed here.

Abstract

Connective tissue growth factor (CTGF), a multifunctional protein of the CCN family, regulates cell proliferation, differentiation, adhesion, and a variety of other biological processes. It is involved in the disease-related pathways such as the Hippo pathway, p53 and nuclear factor kappa-B (NF-B) pathways and thus contributes to the developments of inflammation, fibrosis, cancer and other diseases as a downstream effector. Therefore, CTGF might be a potential therapeutic target for treating various diseases. In recent years, the research on the potential of CTGF in the treatment of diseases has also been paid more attention. Several drugs targeting CTGF (monoclonal antibodies FG3149 and FG3019) are being assessed by clinical or preclinical trials and have shown promising outcomes. In this review, the cellular events regulated by CTGF, and the relationships between CTGF and pathogenesis of diseases are systematically summarized. In addition, we highlight the current researches, focusing on the preclinical and clinical trials concerned with CTGF as the therapeutic target.

Citing Articles

CCN2 mediates fibroblast-macrophage interaction in knee arthrofibrosis based on single-cell RNA-seq analysis.

Li Z, Jiang J, Cai K, Qiao Y, Zhang X, Wang L Bone Res. 2025; 13(1):26.

PMID: 39994205 PMC: 11850813. DOI: 10.1038/s41413-025-00400-9.

Modified bFGF targeting connective tissue growth factor in the injured microenvironment improved cardiac repair after chronic myocardial ischemia.

Sun S, Zhu F, Xu Q, Hou X, Nie W, Su K Regen Ther. 2025; 28:438-450.

PMID: 39925966 PMC: 11803136. DOI: 10.1016/j.reth.2025.01.006.

Endothelial Dysfunction and Impaired Wound Healing Following Radiation Combined Skin Wound Injury.

Wang L, Lin B, Zhai M, Hull L, Cui W, Xiao M Int J Mol Sci. 2024; 25(23).

PMID: 39684207 PMC: 11641134. DOI: 10.3390/ijms252312498.

Elevated reactive aggression in forebrain-specific knockout mice.

Chang H, Ng C, Chen Y, Wang Y, Yu I, Lee L J Cell Commun Signal. 2024; 18(3):e12040.

PMID: 39524137 PMC: 11544641. DOI: 10.1002/ccs3.12040.

A monoallelic variant in CCN2 causes an autosomal dominant spondyloepimetaphyseal dysplasia with low bone mass.

Li S, Shao R, Li S, Zhao J, Deng Q, Li P Bone Res. 2024; 12(1):60.

PMID: 39414788 PMC: 11484961. DOI: 10.1038/s41413-024-00364-2.

References

Kim B, Kim H, Jung S, Moon A, Noh D, Lee Z . A CTGF-RUNX2-RANKL Axis in Breast and Prostate Cancer Cells Promotes Tumor Progression in Bone. J Bone Miner Res. 2019; 35(1):155-166. DOI: 10.1002/jbmr.3869. View

Zhang C, Wu Z, Li J, Tan K, Yang W, Zhao H . Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19. J Med Virol. 2020; 93(3):1378-1386. DOI: 10.1002/jmv.26634. View

Mulsow J, Watson R, Fitzpatrick J, OConnell P . Transforming growth factor-beta promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling. Ann Surg. 2005; 242(6):880-7, discussion 887-9. PMC: 1409881. DOI: 10.1097/01.sla.0000189606.58343.cd. View

Pap D, Veres-Szekely A, Szebeni B, Rokonay R, Onody A, Lippai R . Characterization of IL-19, -20, and -24 in acute and chronic kidney diseases reveals a pro-fibrotic role of IL-24. J Transl Med. 2020; 18(1):172. PMC: 7168946. DOI: 10.1186/s12967-020-02338-4. View

Hinton D, Spee C, He S, Weitz S, Usinger W, Labree L . Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy. Diabetes Care. 2004; 27(3):758-64. DOI: 10.2337/diacare.27.3.758. View

Perelas A, Silver R, Arrossi A, Highland K . Systemic sclerosis-associated interstitial lung disease. Lancet Respir Med. 2020; 8(3):304-320. DOI: 10.1016/S2213-2600(19)30480-1. View

Aikawa T, Gunn J, Spong S, Klaus S, Korc M . Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer. Mol Cancer Ther. 2006; 5(5):1108-16. DOI: 10.1158/1535-7163.MCT-05-0516. View

Maity G, Ghosh A, Gupta V, Haque I, Sarkar S, Das A . CYR61/CCN1 Regulates dCK and CTGF and Causes Gemcitabine-resistant Phenotype in Pancreatic Ductal Adenocarcinoma. Mol Cancer Ther. 2019; 18(4):788-800. DOI: 10.1158/1535-7163.MCT-18-0899. View

Heng E, Huang Y, Black Jr S, Trackman P . CCN2, connective tissue growth factor, stimulates collagen deposition by gingival fibroblasts via module 3 and alpha6- and beta1 integrins. J Cell Biochem. 2006; 98(2):409-20. PMC: 1435777. DOI: 10.1002/jcb.20810. View

10.

Hall-Glenn F, Aivazi A, Akopyan L, Ong J, Baxter R, Benya P . CCN2/CTGF is required for matrix organization and to protect growth plate chondrocytes from cellular stress. J Cell Commun Signal. 2013; 7(3):219-30. PMC: 3709047. DOI: 10.1007/s12079-013-0201-y. View

11.

LeBleu V, Taduri G, OConnell J, Teng Y, Cooke V, Woda C . Origin and function of myofibroblasts in kidney fibrosis. Nat Med. 2013; 19(8):1047-53. PMC: 4067127. DOI: 10.1038/nm.3218. View

12.

Malik A, Liszewska E, Jaworski J . Matricellular proteins of the Cyr61/CTGF/NOV (CCN) family and the nervous system. Front Cell Neurosci. 2015; 9:237. PMC: 4478388. DOI: 10.3389/fncel.2015.00237. View

13.

Khaja F, Jayawardena D, Kuzmis A, Onyuksel H . Targeted Sterically Stabilized Phospholipid siRNA Nanomedicine for Hepatic and Renal Fibrosis. Nanomaterials (Basel). 2017; 6(1). PMC: 5302539. DOI: 10.3390/nano6010008. View

14.

Li S, Pan Y . Immunolocalization of connective tissue growth factor, transforming growth factor-beta1 and phosphorylated-SMAD2/3 during the postnatal tooth development and formation of junctional epithelium. Ann Anat. 2017; 216:52-59. DOI: 10.1016/j.aanat.2017.10.005. View

15.

Ohkawara B, Kobayakawa A, Kanbara S, Hattori T, Kubota S, Ito M . CTGF/CCN2 facilitates LRP4-mediated formation of the embryonic neuromuscular junction. EMBO Rep. 2020; 21(8):e48462. PMC: 7403661. DOI: 10.15252/embr.201948462. View

16.

Perbal B . CCN proteins: multifunctional signalling regulators. Lancet. 2004; 363(9402):62-4. DOI: 10.1016/S0140-6736(03)15172-0. View

17.

Liang H, Xu C, Pan Z, Zhang Y, Xu Z, Chen Y . The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis. Mol Ther. 2014; 22(6):1122-1133. PMC: 4048895. DOI: 10.1038/mt.2014.42. View

18.

Sternlicht M, Wirkner U, Bickelhaupt S, Lopez Perez R, Tietz A, Lipson K . Radiation-induced pulmonary gene expression changes are attenuated by the CTGF antibody Pamrevlumab. Respir Res. 2018; 19(1):14. PMC: 5774112. DOI: 10.1186/s12931-018-0720-4. View

19.

Zhang J, Huang Y, Qiu L, Nickel J, Sebald W . von Willebrand factor type C domain-containing proteins regulate bone morphogenetic protein signaling through different recognition mechanisms. J Biol Chem. 2007; 282(27):20002-14. DOI: 10.1074/jbc.M700456200. View

20.

Lv L, Liu F, Na D, Xu H, Wang Z, Jiang C . Transforming growth factor-β1 induces connective tissue growth factor expression and promotes peritoneal metastasis of gastric cancer. Biosci Rep. 2020; 40(9). PMC: 7502695. DOI: 10.1042/BSR20201501. View